Variables | Cohort, No. (%) |
---|---|
Median age | 64 (range 25~81) |
Sex | |
Male | 94(76.40) |
Female | 29(23.60) |
Smoking status | |
No smoking | 52(42.30) |
Current | 31(25.20) |
Former | 40(32.50) |
Tumor type | |
Lung cancer | 57(46.30) |
Esophageal cancer | 64(52.00) |
Mediastinal malignant fibrous adenoma | 2 (1.60) |
RT modality | |
IMRT | 103(83.74) |
3D-CRT | 15(12.20) |
TOMO | 5 (4.06) |
Total prescribed dose (cGy) | |
≥6000 | 64(52.03) |
5000~6000 | 24(19.51) |
≤5000 | 35(28.46) |
ARE | |
Grade 0-1 | 46(37.40) |
Grade 2-5 | 77(62.60) |
RP | |
Grade 0-1 | 86(69.90) |
Grade 2-5 | 37(30.10) |